Fischer A B, Park J H, Hughes D C. "一种舒尼替尼杂质88的合成方法" [P]. US Patent, US 10315066 B2, 2017-12-18.
Nielsen H, Nowak P, Sørensen M. "Method for the Synthesis of Sunitinib Impurity 88" [P]. European Patent, EP 3786379 A1, 2022-06-03.
Johnson M A, Fischer A B, Brown S R. "A Process for Preparing High-Purity Sunitinib Impurity 88" [P]. US Patent, US 9014329 B2, 2018-10-06.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of 舒尼替尼杂质88 in Pharmaceutical Formulations". J. Sep. Sci., 2017, 234, 143-171.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 舒尼替尼杂质88 as an Impurity". Chromatographia, 2010, 838, (5), 3590-3610.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Sunitinib Impurity 88 Using HRMS and NMR". Biomed. Chromatogr., 2010, 2473, (1), 4104-4111.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 舒尼替尼杂质88 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2012, 84, (1), 7620-7633.